Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Actavia Life Sciences, Inc.

RASP

HealthcareOTCUS

$0.0005

$0.00 (+0.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

RASP

1Y0 (0.00%)

Candles, volume, SMA 20, and SMA 50

O 0.0005H 0.0005L 0.0005C 0.0005Date Jun 5

RASP

SMA 20 SMA 50 Vol 20EEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Actavia Life Sciences, Inc. is a biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. It also develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$385,906

Volume?20

Avg Volume?93.84

52w Range$0.0004 - $0.004

Beta?-64.36

Price Performance

0.0%

$0.0005 to $0.0005

YTD

0.0%